Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy

Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy

Abstract Background To assess the influence of molecular markers with potential prognostic value to groups of patients with newly diagnosed glioblastoma patients were examined: group A with 36 patients (surgical resection plus standard combined chemoradiotherapy) and group B with 36 patients (surgic...

Full description

Bibliographic Details
Main Authors: Steffi Urbschat, Christoph Sippl, Jana Engelhardt, Kai Kammers, Joachim Oertel, Ralf Ketter
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Molecular Cytogenetics
Subjects:
Glioblastoma
CGH
Carmustin wafer
Prognostic factors
Standard combined radiochemotherapy
Online Access:http://link.springer.com/article/10.1186/s13039-017-0317-5

Internet

http://link.springer.com/article/10.1186/s13039-017-0317-5

Similar Items